Background and Overview

Kreido Biofuels, Inc. ("Kreido Biofuels," "we" or the "Company") was incorporated on February 7, 2005 under the name Gemwood Productions. On November 2, 2006, we changed our name to Kreido Biofuels, Inc.





Our registration statement on Form SB-2, file number 333-140718, became
effective on June 28, 2007.  Subsequent to the filing of our Annual Report on
Form 10-K for the year ended December 31, 2008, we continued to file annual and
quarterly reports with the Securities and Exchange Commission on a voluntary
basis through the quarter ended September 30, 2009.  On February 16, 2009, we
elected to terminate our registration and our election to file periodic reports.
On March 2, 2018, we filed a registration statement on Form 10, and the
registration statement became effective on May 8, 2018.



On November 10, 2017, the Company issued 142,924,167 shares of common stock to
Reed Petersen, its then officer and director in consideration of cash of $21,434
paid by him to satisfy accounts payable of the Company, and in conversion of
$150,075 in accounts payable which he had acquired from the owners of that debt.
This transaction was exempt under section 4(2) of the Securities Act of 1933 as
one not involving any public solicitation or public offering, and was also
exempt under Section 4(5) as an offering solely to accredited investors not
involving any public solicitation or public offering.



On June 5, 2018, the Company and its sole officer and director, G. Reed
Petersen, entered into that certain Stock Purchase Agreement (the "Stock
Purchase Agreement"), pursuant to which Mr. Petersen agreed to sell to certain
purchasers an aggregate of 142,924,167 shares of common stock of the Company
(the "Control Shares"), representing approximately 73% of the issued and
outstanding stock of the Company, for aggregate cash consideration of $420,000
in accordance with the terms and conditions of the Stock Purchase Agreement. The
sale of the Control Shares consummated on June 29, 2018. In connection with the
sale of the Control Shares, G. Reed Petersen resigned from his positions as the
sole executive officer and director of the Company, effective June 29, 2018.
 Mr. Petersen's departure was not due to any dispute or disagreement with the
Company on any matter related to the Company's operations, policies or
practices.  Concurrently, the Board of Directors appointed Wai Lim Wong to fill
the vacancies created by Mr. Petersen's resignation, and to serve as the
Company's sole Director, Chief Executive Officer, Chief Financial Officer and
Secretary.


On September 7, 2021, Board of Directors Board of Directors accepted the resignation of Wai Lim Wong, and appointed CHAN Kwok Wai Davy as a new member of the Board of Directors and CEO.





On December 14, 2021, the Company, nine stockholders (the "Selling
Stockholders") and six purchasers (the "Purchasers") entered into a Stock
Purchase Agreement (the "SPA"), pursuant to which the Purchasers agreed to
purchase from the Selling Stockholders 13,099,243 shares of common stock of the
Company, par value $0.001 (collectively, the "Shares"), constituting
approximately 89% of the issued and outstanding shares of common stock of the
Company, for aggregate consideration of Four Hundred Twenty Thousand Dollars
($420,000) in accordance with the terms and conditions of the SPA. The
acquisition of the Shares consummated on December 20, 2021, and the Shares were
ultimately purchased by the following individuals:



Selling Shareholder   No. of Common Stock Purchaser
DOU Chu Ju            554,856             PG MAX & CO, LLC
ZHANG Chao            214,387             CHEN,HSUEH-NI
HEUNG Kin Leung Kenny 55,000              HSIAO, CHUNG-PIN
HEUNG Pak Kuen        55,000              HSIAO, CHUNG-PIN
HEUNG Teui Yee        55,000              HSIAO, YU-CHIAO
KWAN Chin Man         55,000              HSIAO, YU-CHIAO
LEUNG Wong Hung       55,000              HSU, CHENG-HSING
MAK Chit Ming Brian   55,000              HSU, CHENG-HSING

Pang King Sau Nelson 12,000,000 Orient Express & Co., Ltd.



Total                 13,099,243






  6






Orient Express & Co., Ltd. holds a controlling interest in the Company, and may
unilaterally determine the election of the Board and other substantive matters
requiring approval of the Company's stockholders. Cheng Hsing Hsu, our new Chief
Financial Officer and Director, is the director and controlling shareholder of
Orient Express & Co., Ltd.

Upon the consummation of the sale, Chan Kwok Wai Davy, our sole executive officer and director, resigned from all of his positions with the Company, effective December 20, 2021. His resignation was not due to any dispute or disagreement with the Company on any matter relating to the Company's operations, policies or practices.





Concurrently with such resignation, the following individuals were appointed to
serve in the positions set forth next to their names, until the next annual
meeting of stockholders of the Company and until such director's successor is
elected and qualified or until such director's earlier death, resignation or
removal:



Name             Position

HSIAO, Chung Pin Chief Executive Officer and Director HSIAO, Yu-Chiao Secretary and Director HSU, Cheng Hsing Chief Financial Officer and Director






Chung Pin HSIAO and Yu Chiao HSIAO are siblings. Except as set forth in the
foregoing, none of the directors or executive officers has a direct family
relationship with any of the Company's directors or executive officers, or any
person nominated or chosen by the Company to become a director or executive
officer. All officers and directors will serve in his or her positions without
compensation. The Company hopes to enter into a compensatory arrangement with
each officer in the future.



Our current business is to seek to effect a merger, capital stock exchange,
asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses. Our acquisition strategy is to assess a
broad range of potential business combination targets and complete a business
combination. In doing so, we will evaluate the historical financial statements
of the target, its management, and projected future results. In evaluating a
prospective target business, we expect to conduct a thorough due diligence
review that will encompass, among other things, meetings with incumbent
management and employees, document reviews, inspection of facilities, as well as
a review of financial and other information that will be made available to us.



Results of Operations


Following is management's discussion of the relevant items affecting results of operations for the years ended 2021 and 2020.

Revenues. The Company generated revenues of $-0- during the year ended December 31, 2021, as compared to $-0- for the year ended December 31, 2020.





Operating Expenses.  Operating expenses for the year ended December 31, 2021
were $437,966, consisting primarily of professional fees, compared to $11,644
for the year ended December 31, 2020.  The increase is mainly the result of
stock based compensation in relation to consulting service rendered.



We expect operating expenses to increase as we continue our process of identifying prospective acquisition targets and hopefully successfully consummate such an acquisition.

Other Income (Expense). The Company had net other income of $43,149 for the year ended December 31, 2021 compared to $-0- during the year ended December 31, 2020. The increase is mainly due to gain from forgiveness of related party debts.

Net Loss. For the year ended December 31, 2021, the Company had a net loss of $394,817, as compared to $11,644 for the year ended December 31, 2020. The increase in net loss was due to the addition of stock based compensation expense.







  7





Liquidity and Capital Resources

As of December 31, 2021, our primary source of liquidity consisted of $-0- in cash and cash equivalents. Since inception, we have financed our operations through a combination of short and long-term loans, and through the private placement of our common stock.

Going Concern Uncertainties.





We have sustained significant net losses which have resulted in a total
stockholders' deficit as at December 31, 2021 of $755 and are currently
experiencing a substantial shortfall in operating capital which raises doubt
about our ability to continue as a going concern. Until we successfully
consummate an acquisition with an operating company, we expect to continue to
incur net losses. Depending upon the financial profile of our acquired company,
we may continue in our net loss position even after the acquisition of an
operating company. With the expected cash requirements for the coming months,
without additional cash inflows from an increase in revenues combined with
continued cost-cutting or a receipt of cash from capital investment, there is
substantial doubt as to the Company's ability to continue operations.



There is presently no agreement in place with any source of financing for the
Company, and we cannot be assured that the Company will be able to raise any
additional funds, or that such funds will be available on acceptable terms.
Funds raised through future equity financing will likely be substantially
dilutive to current shareholders. Lack of additional funds will materially
affect the Company and its business and may cause us to cease operations.
Consequently, shareholders could incur a loss of their entire investment in the
Company.


Net Cash Used in Operating Activities.





For the year ended December 31, 2021, net cash used in operating activities was
$51,000, which consisted primarily of a net loss of $394,817, $42,174 gain from
the forgiveness of debts and a decrease in account payable of $26,509,
offsetting by stock based compensation expense of $412,500.



For the year ended December 31, 2020, net cash used in operating activities was $-0-, which consisted primarily of a net loss of $11,644, and increase in account payable of $10,535, and an increase in related party payables of $1,109.

Net Cash Used In/Provided By Investing Activities.

There was no net cash used in or provided by investing activities during the year ended December 31, 2021 and 2020.

Net Cash Provided By Financing Activities.

For the year ended December 31, 2021, net cash provided by financing activities was $51,000, from the issuance of promissory note.

For the year ended December 31, 2020, net cash provided by financing activities was $-0-.

Off-Balance Sheet Arrangements





We do not have any off-balance sheet arrangements that have or are reasonably
likely to have a current or future effect on our financial condition, changes in
financial condition, revenues or expenses, results of operations, liquidity,
capital expenditures or capital resources that is material to investors.





  8






Critical accounting policies



The preparation of our financial statements requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities and the disclosure of contingent assets and liabilities at the date
of the financial statements and the reported amounts of revenues and expenses
during the reporting period. On an on-going basis, management evaluates its
estimates and judgments which are based on historical experience and on various
other factors that are believed to be reasonable under the circumstances. The
results of their evaluation form the basis for making judgments about the
carrying values of assets and liabilities. Actual results may differ from these
estimates under different assumptions and circumstances. Our significant
accounting policies are more fully discussed in Note 2 to our financial
statements contained herein.



Recent accounting pronouncements





The recent accounting standards that have been issued or proposed by the FASB or
other standards-setting bodies that do not require adoption until a future date
are not expected to have a material impact on our financial statements upon
adoption.























  9






            Report of Independent Registered Public Accounting Firm

     To the shareholders and the board of directors of Kreido Biofuels Inc

Opinion on the Financial Statements





We have audited the accompanying balance sheets of Kreido Biofuels Inc. (the
"Company") as of December 31, 2021, and 2020 the related statements of
operations, changes in shareholders' equity and cash flows, for each of the two
years in the period ended December 31, 2021, and the related notes collectively
referred to as the "financial statements".



In our opinion, the financial statements present fairly, in all material
respects, the financial position of the Company as of December 31, 2021, and
2020, and the results of its operations and its cash flows for the year ended
December 31, 2021, in conformity with U.S. generally accepted accounting
principles.



Going Concern



The accompanying financial statements have been prepared assuming the company
will continue as a going concern as disclosed in Note 3 to the financial
statement, the Company has continuously incurred a net loss of $394,817 for the
year ended December 31, 2021, and an accumulated deficit of $755 as at December
31, 2021. The continuation of the Company as a going concern through December
31, 2021, is dependent upon improving the profitability and the continuing
financial support from its stockholders. Management believes the existing
shareholders or external financing will provide the additional cash to meet the
Company's obligations as they become due.



These factors raise substantial doubt about the company ability to continue as a
going concern. These financial statements do not include any adjustments that
might result from the outcome of the uncertainty.



Basis for Opinion



These financial statements are the responsibility of the Company's management.
Our responsibility is to express an opinion on the Company's financial
statements based on our audits. We are a public accounting firm registered with
the Public Company Accounting Oversight Board (United States) ("PCAOB") and are
required to be independent with respect to the Company in accordance with the
U.S. federal securities laws and the applicable rules and regulations of the
Securities and Exchange Commission and the PCAOB. We conducted our audits in
accordance with the standards of the PCAOB. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. Our
audits included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and
performing procedures that respond to those risks. Such procedures included
examining, on a test basis, evidence regarding the amounts and disclosures in
the financial statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as well as
evaluating the overall presentation of the financial statements. We believe that
our audits provide a reasonable basis for our opinion. The company is not
required to have, nor were we engaged to perform, an audit of its internal
control over financial reporting. As part of our audits, we are required to
obtain an understanding of internal control over financial reporting but not for
the purpose of expressing an opinion on the effectiveness of the Company's
internal control over financial reporting. Accordingly, we express no such
opinion.





OLAYINKA OYEBOLA & CO.

(Chartered Accountants)



March [•], 2022.



Lagos Nigeria

We have served as the Company's auditor since September 2020.





PCAOB Number: {5968}





  10








                             Kreido Biofuels, Inc.
                                 Balance Sheets





                                                       December 31,      December 31,
                                                           2021              2020

                       ASSETS

CURRENT ASSETS

Cash                                                   $           -     $           -

TOTAL ASSETS                                                       -                 -

LIABILITIES AND STOCKHOLDERS' DEFICIT



CURRENT LIABILITIES

Accounts Payable                                       $         755     $      35,817
Related Party Payable                                              -            33,621

Total Current Liabilities                                        755            69,438

Total Liabilities                                                755            69,438

STOCKHOLDERS' DEFICIT

Preferred stock; 10,000,000 shares authorized, at
$0.001 par value, 0 shares issued and outstanding                  -        

-


Common stock; 300,000,000 shares authorized, at
$0.001 par value, 14,706,513 and 1,956,452 shares
issued and outstanding, respectively                          14,706             1,956
Additional paid-in capital                                49,435,627        48,984,877
Accumulated Deficit                                      (49,451,088 )     (49,056,271 )

Total Stockholders' Deficit                                     (755 )         (69,438 )

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT            $           -     $           -



The accompanying notes are an integral part of these financial statements.







  11




--------------------------------------------------------------------------------
                             Kreido Biofuels, Inc.
                            Statements of Operations





                                                             For the Years Ended
                                                                December 31,
                                                           2021              2020

REVENUES                                               $           -     $           -

EXPENSES
Professional Fees                                            424,816             5,000
General and administrative                                    13,150             6,644
Total operating expenses                                     437,966            11,644

LOSS FROM OPERATIONS                                        (437,966 )         (11,644 )

OTHER INCOME
Gain on settlement of debt                                    43,149                 -

Total other income                                            43,149                 -

LOSS BEFORE INCOME TAXES                                    (394,817 )         (11,644 )

PROVISION FOR INCOME TAXES                                         -                 -

NET LOSS                                               $    (394,817 )   $     (11,644 )

BASIC AND DILUTED LOSS PER SHARE                       $       (0.13 )   $  

(0.01 )



BASIC AND DILUTED WEIGHTED AVERAGE NUMBER OF COMMON
SHARES OUTSTANDING                                         2,966,930         1,956,452





   The accompanying notes are an integral part of these financial statements



  12






                             Kreido Biofuels, Inc.
                      Statements of Stockholders' Deficit




                                                               Additional                             Total
                                     Common Stock               Paid-In         Accumulated       Stockholders'
                                 Shares          Amount         Capital           Deficit            Deficit

Balance, December 31, 2017 $ 1,956,452 $ 1,956 $ 48,963,527

$ (48,972,333 ) $ (6,850 )



Gain on forgiveness of debt              -              -           21,350                 -              21,350

Net loss for the year
December 31, 2018                        -              -                -           (38,958 )           (38,958 )

Balance, December 31, 2018 $ 1,956,452 $ 1,956 $ 48,984,877

   $ (49,011,291 )   $       (24,458 )

Net loss for the year
December 31, 2019                        -              -                -           (33,336 )           (33,336 )

Balance, December 31, 2019 $ 1,956,452 $ 1,956 $ 48,984,877

   $ (49,044,627 )   $       (57,794 )

Net loss for the year
December 31, 2020                        -              -                -           (11,644 )           (11,644 )

Balance, December 31, 2020 $ 1,956,452 $ 14,706 $ 48,984,877

$ (49,056,271 ) $ (69,438 )



Fractional shares                       61              -                -                 -                   -
Shares issued for service
rendered                           750,000            750          411,750                 -             412,500
Shares issued for the
conversion of promissory
note                            12,000,000         12,000           39,000                 -              51,000
Net loss for the year
December 31, 2021                        -              -                -          (394,817 )          (394,817 )

Balance, December 31, 2021 $ 14,706,513 $ 14,706 $ 49,435,627

   $ (49,451,088 )   $          (755 )




   The accompanying notes are an integral part of these financial statements.





  13






                             Kreido Biofuels, Inc.
                            Statements of Cash Flows


                                                             For the Years Ended
                                                                December 31,
                                                           2021              2020

CASH FLOWS FROM OPERATING ACTIVITIES
Net loss                                               $    (394,817 )   $     (11,644 )
Adjustments to reconcile net loss to net cash used
in operating activities:
Stock based compensation                                     412,500        

-


Gain from the forgiveness of debt                            (42,174 )      

-


Changes in operating assets and liabilities:
Change in accounts payable related party                           -        

1,109


Change in accounts payable                                   (26,509 )      

10,535

Net Cash Used in Operating Activities                        (51,000 )      

-



CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from promissory note                                 51,000        

-



Net Cash Provided by Financing Activities                     51,000        

-


Net cash provided by investing activities                          -                 -
NET INCREASE IN CASH                                               -                 -

CASH AT BEGINNING OF YEAR                                          -                 -

CASH AT END OF YEAR                                    $           -     $           -

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
CASH PAID FOR:
Interest                                               $           -     $           -
Income Taxes                                           $           -     $           -

NON-CASH INVESTING AND FINANCING ACTIVITIES
Stock issued for debt                                  $      51,000     $           -




   The accompanying notes are an integral part of these financial statements.



  14




                             Kreido Biofuels, Inc.

                         Notes to financial statements

                      For the year ended December 31, 2021




NOTE 1 - ORGANIZATION AND BUSINESS OPERATIONS





Nature of Business



Kreido Biofuels, Inc. (the "Company" or "KRBF") was incorporated as Gemwood
Productions, Inc. under the laws of the State of Nevada on February 7, 2005.
Gemwood Productions, Inc. changed its name to Kreido Biofuels, Inc. on
November 2, 2006. The Company took its current form on January 12, 2007 when
Kreido Laboratories, Inc. ("Kreido Labs"), completed a reverse triangular merger
with Kreido Biofuels, Inc.



Kreido Labs, formerly known as Holl Technologies Company, was incorporated on
January 13, 1995 under the laws of the State of California. Since incorporation,
Kreido Labs has been engaged in activities required to develop, patent and
commercialize its products. Kreido Labs was the creator of reactor technology
that was designed to enhance the manufacturing of a broad range of chemical
products.



The cornerstone of Kreido Labs' technology was its patented STT® (Spinning Tube
in Tube) diffusional chemical reacting system, which were both a licensable
process and a licensable system. In 2005, the Company demonstrated how the
STT® could make biodiesel from vegetable oil rapidly with almost complete
conversion and less undesirable by-products. The Company had continued to pursue
this activity, built and tested a pilot biodiesel production unit and, prior to
June 20, 2008, was in the process of developing the first of its commercial
biodiesel production plants in the United States that, if constructed and put
into operation, was expected to produce approximately 33 million to 50 million
gallons per year. On June 20, 2008, the Company announced that due to the
weakening of the economy, the continued financial market turmoil and the
inability to raise needed capital to finance site construction and plant
start-up costs, the Company was suspending work regarding its flagship biodiesel
production plant at the Port of Wilmington, North Carolina. In November of 2018,
the Company discontinued operations of its subsidiary, Kreido Labs.



Our current business will be to seek to effect a merger, capital stock exchange,
asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses. We have not selected any specific
business combination target and we have not, nor has anyone on our behalf,
initiated any substantive discussions, directly or indirectly, with any business
combination target.



Our acquisition strategy will be to assess a broad range of potential business
combination targets and complete a business combination.  In doing so, we will
evaluate the historical financial statements of the target, its management, and
projected future results. In evaluating a prospective target business, we expect
to conduct a thorough due diligence review that will encompass, among other
things, meetings with incumbent management and employees, document reviews,
inspection of facilities, as well as a review of financial and other information
that will be made available to us.



We are not prohibited from pursuing a business combination with a company that
is affiliated with our management, but we have no plans to do so. We do not plan
to retain a significant equity position after closing of any acquisition and
management does not plan to continue as part of the new management team.



We have not selected any specific business combination target. Our sole officer
and director presently has, and in the future may have additional, fiduciary or
contractual obligations to other entities pursuant to which such officer or
director is or will be required to present a business combination opportunity.
Accordingly, if our officer and director becomes aware of a business combination
opportunity which is suitable for an entity to which he or she has then-current
fiduciary or contractual obligations, he or she will honor his or her fiduciary
or contractual obligations to present such opportunity to such entity. We do not
believe, however, that the fiduciary duties or contractual obligations of our
officer/director will materially affect our ability to complete our business
combination.



Our executive officer is not required to commit any specified amount of time to
our affairs, and, accordingly, will have conflicts of interest in allocating
management time among various business activities, including identifying
potential business combination targets and monitoring the related due diligence.



On December 14, 2021, certain shareholders owning 13,099,243 of our common stock, representing a majority of issued and outstanding shares, agreed to sell their shares to 6 shareholders. This constitutes a change in control of the Company.







  15





NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.

Accounting Estimates



The preparation of the financial statements in conformity with generally
accepted accounting principles in the United States of America requires
management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at
the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those
estimates.


Fair Value of Financial Instruments



Financial instruments, including cash and accrued expenses and other liabilities
are carried at amounts, which reasonably approximate their fair value due to the
short-term nature of these amounts or due to variable rates of interest, which
are consistent with market rates.



Loss per Common Share



Basic loss per share is calculated by dividing the Company's net loss applicable
to common shareholders by the weighted average number of common shares during
the period. Diluted earnings per share is calculated by dividing the Company's
net income available to common shareholders by the diluted weighted average
number of shares outstanding during the year.



Stock-based compensation

The Company recognizes compensation expense for all stock-based compensation awards based on the grant-date fair value estimated in accordance with the provisions of ASC 718.





Income Taxes

Under ASC 740, "Income Taxes," deferred tax assets and liabilities are
recognized for the future tax consequences attributable to temporary differences
between the financial statement carrying amounts of existing assets and
liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the
years in which those temporary differences are expected to be recovered or
settled. Valuation allowances are established when it is more likely than not
that some or all of the deferred tax assets will not be realized. As of December
31, 2021 [there were no deferred taxes as there was a full valuation allowance
due to the uncertainty of the realization of net operating loss carry forward
prior to expiration.]


Fair Value of Financial Instruments



The Company follows guidance for accounting for fair value measurements of
nonfinancial items that are recognized or disclosed at fair value in the
financial statements on a recurring basis. Additionally, the Company adopted
guidance for fair value measurement related to nonfinancial items that are
recognized and disclosed at fair value in the financial statements on a
nonrecurring basis. The guidance establishes a fair value hierarchy that
prioritizes the inputs to valuation techniques used to measure fair value. The
hierarchy gives the highest priority to unadjusted quoted prices in active
markets for identical assets or liabilities (Level 1 measurements) and the
lowest priority to measurements involving significant unobservable inputs (Level
3 measurements). The three levels of the fair value hierarchy are as follows:



Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.





Level 3 inputs are unobservable inputs for the asset or liability. The carrying
amounts of financial assets such as cash approximate their fair values because
of the short maturity of these instruments.





  16





Recent Accounting Pronouncements

The FASB established the Accounting Standards Codification ("Codification" or "ASC") as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States ("GAAP").

Rules and interpretative releases of the Securities and Exchange Commission ("SEC") issued under authority of federal securities laws are also sources of GAAP for SEC registrants.





Other accounting standards that have been issued or proposed by FASB that do not
require adoption until a future date are not expected to have a material impact
on the financial statements upon adoption. The Company does not discuss recent
pronouncements that are not anticipated to have an impact on or are unrelated to
its financial condition, results of operations, cash flows or disclosures.



NOTE 3 - GOING CONCERN



In order to continue as a going concern, the Company will need, among other
things, additional capital resources. Management's plan is to obtain such
resources for the Company by obtaining capital from management sufficient to
meet its minimal operating expenses and seeking equity and/or debt financing.
However, Management cannot provide any assurances that the Company will be
successful in accomplishing any of its plans, which raises substantial doubt
about the ability of the Company to continue as a going concern.



The ability of the Company to continue as a going concern is dependent upon its
ability to successfully accomplish the plans described in the preceding
paragraph and eventually secure other sources of financing and attain profitable
operations. The accompanying financial statements do not include any adjustments
that might be necessary if the Company is unable to continue as a going concern.



NOTE 4 - STOCKHOLDERS' EQUITY





Common Stock



The Company's Articles of Incorporation authorize the issuance of up to
300,000,000 common shares, par value $0.001 per share, and 10,000,000 preferred
shares, also $0.001 par value. There were 14,706,513 and 1,956,452 shares of
common stock outstanding at December 31, 2021 and 2020, respectively. There were
no preferred shares outstanding during any periods presented.



During the year ended December 31, 2021, a related party forgave an outstanding
balance of $33,621 and the forgiveness of related party debt was recorded in
additional paid-in capital.



On October 15, 2021, the Company issued 750,000shares of its common stock to a
third party for services rendered, at the current market value of $0.55 per
share, totaling $412,500 as stock-based compensation recorded for the year ended
December 31, 2021.



In September 2021, the Company received a promissory note of $51,000 in a term
of 3 months with interest charge at 12% per annum. In December 2021, upon the
maturity, the Company converted the promissory note of $12,000 into 12,000,000
shares of its common stock and the corresponding outstanding balance and
interest charge was waived by the note holder.



There were 14,706,513 and 1,956,452 shares of common stock outstanding at December 31, 2021 and 2020, respectively. There were no preferred shares outstanding during any years presented.





NOTE 5 - INCOME TAXES



On December 22, 2017, the 2019 Tax Cuts and Jobs Act (the "Tax Act") was enacted
into law including a one-time mandatory transition tax on accumulated foreign
earnings and a reduction of the corporate income tax rate to 21% effective
January 1, 2018, among others. We are required to recognize the effect of the
tax law changes in the period of enactment, such as determining the transition
tax, remeasuring our U.S. deferred tax assets and liabilities as well as
reassessing the net realizability of our deferred tax assets and liabilities.
The Company does not have any foreign earnings and therefore, we do not
anticipate the impact of a transition tax.





  17






We have remeasured our U.S. deferred tax assets at a statutory income tax rate
of 21%. Since the Tax Act was passed late in the fourth quarter of 2017, and
ongoing guidance and accounting interpretation are expected over the next 12
months, we consider the accounting of any transition tax, deferred tax
re-measurements, and other items to be incomplete due to the forthcoming
guidance and our ongoing analysis of final year-end data and tax positions. We
expect to complete our analysis within the measurement period in accordance with
SAB 118, no later than 2020.


The cumulative tax effect at the expected rate of 21% as of December 31, 2021 and 2020 of significant items comprising our net deferred tax amount is as follows:





Schedule of deferred tax assets       2021              2020
Net operating loss carryover      $  49,451,088     $  49,056,271
Deferred tax asset                   10,384,728        10,301,817
Impact of rate changes
Less: valuation allowance           (10,384,728 )     (10,301,817 )
Net deferred tax asset            $           -     $           -




At December 31, 2021, the Company had net operating loss carry forwards of
approximately $49,451,088 that may be offset against future taxable income. The
Tax Act also changed the rules on net operating loss carry forwards. The 20-year
limitation was eliminated, giving the taxpayer the ability to carry forward
losses indefinitely. However, NOL carry forward arising after January 1, 2020,
will now be limited to 80 percent of taxable income.



No tax benefit has been reported in the December 31, 2021, the Company's
financial statements since the potential tax benefit is offset by a valuation
allowance of the same amount.  Due to the change in ownership provisions of the
Tax Reform Act of 1986, net operating loss carry forwards for federal income tax
reporting purposes are subject to annual limitations. A change in ownership may
limit net operating loss carry forwards in future years.   The benefits of our
deferred tax assets, including our NOLs, built-in losses and tax credits would
be reduced or potentially eliminated if we experienced an "ownership change"
under Section 382.



Based on our analysis performed as of December 31, 2021, the Company has
experienced an ownership change as defined by Section 382, and, therefore, the
NOLs, built-in losses and tax credits we have generated should be subject to a
Section 382 limitation as of this reporting date.



NOTE 6 - RELATED PARTY TRANSACTIONS





During the year ended December 31, 2021, a related party forgave an outstanding
balance of $33,621 and the forgiveness of related party debt was recorded in
additional paid-in capital. As of December 31, 2020, the Company had a zero
balance of related party payable.



During the year ended December 31, 2021, the Company has been provided with free
office space by its shareholders. The management determined that such cost is
nominal and did not recognize the rent expense in its financial statements.



Apart from the transactions and balances detailed elsewhere in these accompanying financial statements, the Company has no other significant or material related party transactions during the years presented.

NOTE 7 - COMMITMENTS AND CONTINGENCIES

As of December 31, 2021, the Company has no material commitments or contingencies.





NOTE 8 - SUBSEQUENT EVENTS



The Company has evaluated subsequent events from December 31, 2021, through the date the financial statements were issued and there have been no subsequent events for which disclosure is required.









  18

© Edgar Online, source Glimpses